new-recommended-broker-banner new-recommended-broker-banner

Shockwave Medical Inc (SWAV)- DEVELOPS PRODUCTS IN CARDIOVASCULAR MEDICINE

Updated: 31 Aug 2021

Entry level: $195 early entry with potential add-on if it goes past $292.50 to ATH

Price target: $230-$240, or waiting for the 10-day MA and/or 21-day EMA break if the trend gets going

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .